Early beta blocker use increases STEMI mortality

Early use of beta-blockers decreases short-term morbidity in patients with ST-elevation but is associated with increased in-hospital mortality, an analysis of GRACE data shows.

A new study co-authored by Dr David Brieger of the Concord Repatriation General Hospital Coronary Care Unit, Sydney, has prompted calls for prospective trials to further investigate the possible adverse outcomes of early oral beta-blocker use in patients with ST elevation acute MI.

The review of data from 13,110 STEMI patients found that  90% of eligible patients received some form of beta